DMF was previously shown to exert a double mechanism of Nrf2 activation by disrupting the KEAP1/Nrf2 interaction and through the glycogen synthase kinase 3 beta (GSK3β)/Nrf2 signaling pathway, in a tauopathy mouse model [23]. This evidence concerns the gene KEAP1 and tauopathy.